Last 0.66 NOK
Change Today 0.00 / 0.00%
Volume 0.0
DIAG On Other Exchanges
Symbol
Exchange
Berlin
As of 10:25 AM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

diagenic asa (DIAG) Snapshot

Open
0.67 NOK
Previous Close
0.66 NOK
Day High
0.67 NOK
Day Low
0.63 NOK
52 Week High
02/26/14 - 1.98 NOK
52 Week Low
12/16/13 - 0.46 NOK
Market Cap
106.9M
Average Volume 10 Days
1.7M
EPS TTM
-1.06 NOK
Shares Outstanding
162.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DIAGENIC ASA (DIAG)

Related News

No related news articles were found.

diagenic asa (DIAG) Related Businessweek News

No Related Businessweek News Found

diagenic asa (DIAG) Details

DiaGenic ASA researches, develops, sells, and markets blood based gene expression tests. The company was founded in 1998 and is headquartered in Oslo, Norway.

11 Employees
Last Reported Date: 03/21/14
Founded in 1998

diagenic asa (DIAG) Top Compensated Officers

Chief Financial Officer
Total Annual Compensation: 1.2M NOK
Compensation as of Fiscal Year 2013.

diagenic asa (DIAG) Key Developments

DiaGenic ASA to Approve Amendments to the Articles of Association

DiaGenic ASA announced that its shareholders at the Extraordinary General Meeting to be held on October 9, 2014 will consider and approve the amendment of the articles of association related to new company name and amendment of the Articles of Association according to new objective.

DiaGenic ASA, Special/Extraordinary Shareholders Meeting, Oct 09, 2014

DiaGenic ASA, Special/Extraordinary Shareholders Meeting, Oct 09, 2014., at 10:00 Central European Standard Time. Location: Sjølyst plass 2. Agenda: To elect chairman of the meeting and one person to co-sign the minutes; to approve the notice of and the agenda for the meeting; to approve acquisition of the shares in New NEL Hydrogen Holding AS; to approve share capital increase ­ issue of consideration shares; to approve share capital increase ­ private placement; to approve share capital increase ­ rights issue; to approve amendment of the articles of association ­ new company name; and to approve amendment of the articles of association ­ new objective.

DiaGenic ASA, Q2 2014 Earnings Call, Aug 21, 2014

DiaGenic ASA, Q2 2014 Earnings Call, Aug 21, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DIAG:NO 0.00 NOK 0.00

DIAG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DiaxonHit €0.50 EUR 0.00
View Industry Companies
 

Industry Analysis

DIAG

Industry Average

Valuation DIAG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 930.0x
Price/Book 1.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 798.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DIAGENIC ASA, please visit www.diagenic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.